Huhtamaki's CEO Charles Héaulmé to go on leave of absence. Huhtamäki Oyj's CEO Charles Héaulmé has been diagnosed with a cancer which has a very good recovery prognosis but requires a treatment period. He will therefore be taking a leave of absence from early January, to undergo treatment.

He is expected back in second quarter 2022. Thomas Geust, CFO, has been appointed as interim Deputy CEO of Huhtamäki Oyj, effective January 1, 2022. Thomas will report to the Board of Directors and will assume the duties of the CEO until the end of Charles' leave of absence.